Dienogest inhibits Toll-like receptor 4 expression induced by costimulation of lipopolysaccharide and high-mobility group box 1 in endometrial epithelial cells
Dienogest was found to inhibit the expression of Toll-like receptor 4, which was induced by the combined stimulation of lipopolysaccharide and high-mobility group box 1 in endometrial epithelial cells.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (28)
- Dienogest: a review of its use in the treatment of endometriosis via openalex
- Dienogest, a synthetic progestin, inhibits prostaglandin E2 production and aromatase expression by human endometrial epithelial cells in a spheroid culture system via openalex
- Dienogest, a synthetic progestin, inhibits the proliferation of immortalized human endometrial epithelial cells with suppression of cyclin D1 gene expression via openalex
- Dienogest inhibits BrdU uptake with G0/G1 arrest in cultured endometriotic stromal cells via openalex
- Dienogest is as effective as intranasal buserelin acetate for the relief of pain symptoms associated with endometriosis--a randomized, double-blind, multicenter, controlled trial via openalex
- Distinct mechanisms regulate cyclooxygenase-1 and -2 in peritoneal macrophages of women with and without endometriosis via openalex
- Escherichia coli contamination of menstrual blood and effect of bacterial endotoxin on endometriosis via openalex
- Estrogen receptor-beta, estrogen receptor-alpha, and progesterone resistance in endometriosis via openalex
- Progesterone and progestational compounds attenuate tumor necrosis factor alpha-induced interleukin-8 production via nuclear factor kappa B inactivation in endometriotic stromal cells via openalex
- TLR3 and TLR4 expression in healthy and diseased human endometrium via openalex
- Toll-like receptor 4-mediated growth of endometriosis by human heat-shock protein 70 via openalex
- doi:10.4049/jimmunol.0900390 via openalex
- doi:10.1111/j.1447-0578.2007.00189.x via openalex
- doi:10.1016/j.cellbi.2007.01.034 via openalex
- doi:10.1089/vim.2010.0080 via openalex
- doi:10.1093/humrep/dep469 via openalex
- doi:10.1210/jc.2004-0241 via openalex
- doi:10.1038/sj.cdd.4401850 via openalex
- doi:10.1111/j.1447-0756.2009.01076.x via openalex
- doi:10.1159/000212061 via openalex
- doi:10.1016/s0002-9440(10)63583-3 via openalex
- doi:10.1016/j.biocel.2009.10.009 via openalex
- doi:10.1152/ajpcell.00401.2005 via openalex
- doi:10.1016/j.smim.2006.12.002 via openalex
- doi:10.1016/j.imlet.2009.07.003 via openalex
- doi:10.1002/art.10540 via openalex
- doi:10.1016/j.molmed.2007.09.002 via openalex
- doi:10.1016/j.jmig.2009.06.017 via openalex
Cited by (20)
- The Therapeutic Role of Dienogest in Endometriosis-Associated Pain: From Basics to Clinics 2026
- Azurocidin is associated with dienogest-resistance in ovarian endometriotic cysts 2024
- DETERMINATION OF IL-1β mRNA GENE EXPRESSION AND HMGB-1 mRNA GENE EXPRESSION IN WOMEN WITH GENITAL ENDOMETRIOSIS ASSOCIATED WITH INFERTILITY AT THE STAGE OF PREPARATION FOR ASSISTED REPRODUCTIVE TECHNOLOGIES 2024
- [Psychoemotional state and sexual function in women with chronic pelvic pain in genital endometriosis] 2024
- The Role of NF-κB in Endometrial Diseases in Humans and Animals: A Review 2023
- Efficacy and Safety of Dienogest in the Management of Women with Endometriosis; Systematic Review and Meta-Analysis 2023
- Pattern-recognition receptors in endometriosis: A narrative review 2023
- Role of estrogen and estrogen-related factors in endometriosis 2021
- Systematic review and Meta-analysis of efficacy and safety of dienogest in treatment of endometriosis 2021
- The effectiveness of therapy for endometriosis-associated pelvic pain resistant to surgical treatment 2021
- Long-term treatment of endometriosis with dienogest: retrospective analysis of efficacy and safety in clinical practice 2018
- Aromatase as a target for treating endometriosis 2018
- Investigational Medical Therapies for Endometriosis: Current Data and Future Trends 2017
- Dienogest for Treatment of Endometriosis in Chinese Women: A Placebo-Controlled, Randomized, Double-Blind Phase 3 Study 2017
- High Expression of High-Mobility Group Box 1 in Menstrual Blood: Implications for Endometriosis 2017
- Dienogest reduces HSD17β1 expression and activity in endometriosis 2015
- Does dienogest influence the inflammatory response of endometriotic cells? A systematic review 2015
- Dienogest, a synthetic progestin, down-regulates expression of CYP19A1 and inflammatory and neuroangiogenesis factors through progesterone receptor isoforms A and B in endometriotic cells 2014
- Dienogest improves human leucocyte antigen-DR underexpression and reduces tumour necrosis factor-α production in peritoneal fluid cells from women with endometriosis 2014
- Dienogest inhibits nerve growth factor expression induced by tumor necrosis factor-α or interleukin-1β 2013
Source provenance
- openalex
- last seen: 2026-05-14T06:07:48.142452+00:00
- pubmed
- last seen: 2026-10-08T21:09:35.770675+00:00